Stivarga Side Effects
Generic name: regorafenib
Medically reviewed by Drugs.com. Last updated on May 9, 2023.
Note: This document contains side effect information about regorafenib. Some dosage forms listed on this page may not apply to the brand name Stivarga.
Common side effects of Stivarga include: infection, anemia, asthenia, diarrhea, fatigue, fever, hemorrhage, hyperbilirubinemia, hypertension, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, increased amylase, increased inr, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum lipase, lymphocytopenia, mucositis, neutropenia, pain, palmar-plantar erythrodysesthesia, proteinuria, skin rash, thrombocytopenia, voice disorder, weight loss, and decreased appetite. Continue reading for a comprehensive list of adverse effects.
Applies to regorafenib: oral tablet.
Oral route (Tablet)
Severe and sometimes fatal hepatotoxicity has occurred with regorafenib therapy. Monitor hepatic function prior to and during therapy. Adjust dose or interrupt or discontinue therapy if hepatoxicity occurs.
Serious side effects of Stivarga
Along with its needed effects, regorafenib (the active ingredient contained in Stivarga) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking regorafenib:
- Bleeding gums
- bloody or cloudy urine
- blurred vision
- cough or hoarseness
- coughing up blood
- difficult, burning, or painful urination
- difficulty with breathing or swallowing
- fever or chills
- frequent urge to urinate
- increased menstrual flow or vaginal bleeding
- lower back or side pain
- painful or difficult urination
- pounding in the ears
- prolonged bleeding from cuts
- red or black, tarry stools
- redness, swelling, or pain of the skin
- scaling of the skin on the hands and feet
- slow or fast heartbeats
- tingling of the hands and feet
- ulcers on the skin
- Chest pain or discomfort
- dark-colored urine
- general feeling of tiredness or weakness
- light-colored stools
- nausea or vomiting
- pain or discomfort in the arms, jaw, back, or neck
- shakiness in the legs, arms, hands, or feet
- stomach pain that continues
- yellow eyes or skin
- Blistering, peeling, or loosening of the skin
- bloody, black, or tarry stools
- joint or muscle pain
- red skin lesions, often with a purple center
- severe stomach pain, cramping, or burning
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
- trouble breathing
- unusual tiredness or weakness
- vomiting of material that looks like coffee grounds, severe and continuing
Other side effects of Stivarga
Some side effects of regorafenib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Bad, unusual, or unpleasant taste
- hair loss or thinning of the hair
- lack or loss of strength
- muscle or joint stiffness
- weight loss
For Healthcare Professionals
Applies to regorafenib: oral tablet.
Very common (10% or more): Increased AST (93%), hyperbilirubinemia (78%), increased ALT (70%)
Common (1% to 10%): Acute kidney injury
Uncommon (0.1% to 1%): Severe liver injury
Frequency not reported: Hepatic failure[Ref]
Very common (10% or more): Proteinuria (84%)
Common (1% to 10%): Hyperuricemia[Ref]
Common (1% to 10%): Leukopenia[Ref]
Very common (10% or more): Hand-food skin reaction/palmar-plantar erythrodysesthesia syndrome (67%), rash (30%), alopecia (24%)
Common (1% to 10%): Exfoliative rash, dry skin, nail disorder
Uncommon (0.1% to 1%): Erythema multiforme
Very common (10% or more): Asthenia/fatigue (64%), pain (60%), infection (32%), fever (28%), mucosal inflammation (17%)
Very common (10% or more): Hypertension (59%), hemorrhage (21%)
Very common (10% or more): Diarrhea (47%), increased lipase (46%), mucositis (40%), increased amylase (26%), stomatitis (25%), nausea (20%), vomiting (17%)
Uncommon (0.1% to 1%): GI fistula, GI perforation[Ref]
Very common (10% or more): Dysphonia (39%)
Common (1% to 10%): Epistaxis[Ref]
Very common (10% or more): Headache (16%)
Uncommon (0.1% to 1%): Hypersensitivity reaction[Ref]
More about Stivarga (regorafenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Related treatment guides
1. Godfraind T. [Pharmacology of digitalis receptors]. Bull Acad R Med Belg. 1972;12:403-48.
2. Cerner Multum, Inc. UK Summary of Product Characteristics.
3. Cerner Multum, Inc. Australian Product Information.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.